Case report of a combined albendazole and praziquantel therapy in an adult female with neurocysticercosis and generalized tonic-clonic seizures

Cite this:
[1]
K. I. Petrov, “Case report of a combined albendazole and praziquantel therapy in an adult female with neurocysticercosis and generalized tonic-clonic seizures”, ijmhs, vol. 8, no. 2, Mar. 2018.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
472
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS

Abstract

The use of albendazole monotherapy has been favored as the treatment option for neurocysticercosis. This case reports an incidence of neurocysticercosis in a 32-year-old woman who presented to the emergency department with a generalized tonic-clonic seizure. Neurocysticercosis was confirmed by MRI of the brain and positive Taenia solium serologic test. The patient was treated with combined dual therapy of albendazole and praziquantel at standard doses for a minimum effective duration of 14 days in the setting of scarce patient resources. She tolerated therapy without any adverse reactions and remained seizure free. Repeat MRI scan post-treatment revealed the complete eradication of cysticerci. Clinicians should be aware of and consider the efficacy and safety of combined albendazole and praziquantel therapy for the treatment of neurocysticercosis.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”